BeOne Medicines Ltd. (ONC) Form 10-Q Quarterly Reports
BeOne Medicines Ltd. (ONC) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ONC
CIK: 1651308
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerWilliam Williamson
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-15 | 2026-10-13 | FORM 4 | 0001662982-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001980648-26-000027 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-28 | FORM 4 | 0001662982-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-09-30 | — | 144 Filing | 0001950047-26-009885 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-16 | — | SCHEDULE 13D/A Filing | 0001104659-26-108269 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | 4 | 0001193125-26-393103 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-08 | FORM 4 | 0001662982-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-09-08 | — | 144 Filing | 0001950047-26-009194 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | FORM 4 | 0001675628-26-000003 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001950047-26-008907 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-25 | FORM 4 | 0001739452-26-000011 | View SEC Doc Filr Page |
| 8-K | 2026-08-26 | 2026-08-26 | 8-K | 0001651308-26-000025 | View SEC Doc Filr Page |
| 144 | 2026-08-25 | — | 144 Filing | 0001950047-26-008690 | View SEC Doc Filr Page |
| 144 | 2026-08-25 | — | 144 Filing | 0001950047-26-008641 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | FORM 4 | 0001980648-26-000024 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | FORM 4 | 0001042047-26-000019 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001950047-26-007966 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001950047-26-007895 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | FORM 4 | 0002031182-26-000005 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001628280-26-052878 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001628280-26-052877 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | FORM 4 | 0001980648-26-000021 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001950047-26-007567 | View SEC Doc Filr Page |
| 144 | 2026-07-30 | — | 144 Filing | 0001950047-26-007443 | View SEC Doc Filr Page |
| 4 | 2026-07-24 | 2026-07-22 | FORM 4 | 0001980648-26-000019 | View SEC Doc Filr Page |